Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 7 Sept 2026Clinical review pending
!
A visual symptom is not automatically migraine
Sudden persistent loss, an abrupt monocular curtain, a new focal neurological deficit or a severe thunderclap headache can indicate retinal ischaemia, stroke or another emergency.
Action: Arrange immediate emergency assessment for persistent acute loss or stroke features. A resolved suspected retinal or cerebral TIA still needs immediate referral for assessment within twenty-four hours; do not delay that pathway for a migraine diary or triptan trial.
Synopsis
Identify a typical visual aura, distinguish retinal and cerebral emergencies, and manage established migraine without overlooking atypical visual symptoms.
Typical aura is fully reversible, develops gradually over at least five minutes and lasts five to sixty minutes.
Visual aura may include spreading zigzags, shimmering edges, spots or a missing area, and can occur without headache.
A cortical aura affects visual space represented in both eyes, although the patient may initially describe it as one-eye trouble.
Key red flags
A first or changed visual episode with persistent loss, focal weakness or sudden severe headache requires urgent assessment for a secondary cause.
Investigation priorities
01
Structured history and bedside examinationFirst step
Determine whether the event fits a typical reversible aura or needs urgent alternative assessment.
Management branches
EmergencyPersistent or vascular-pattern visual symptoms
The event is abrupt, persistent, strictly monocular with ischaemic features or accompanied by acute neurological red flags.
Arrange immediate emergency assessment for ongoing visual loss, stroke features or thunderclap headache and record symptom timing.
If a resolved event is suspected to be a TIA, use the urgent TIA pathway rather than waiting for another episode.
Key medicines
Sumatriptan tablets for established migraine headacheFor adults covered by the cited tablet SmPC, take 50 mg orally at headache onset; some require 100 mg. If there was an initial response followed by recurrence, a further dose may be taken after at least two hours, with a maximum of 300 mg in twenty-four hours. Do not repeat for the same attack if the first dose did not work. In mild-to-moderate hepatic insufficiency, consider a lower 25–50 mg dose.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.
NICE CG150: Headaches in over 12sTypical and atypical aura features, imaging decisions, acute treatment and medication-overuse advice.
NANOS: Migraine visual auraProfessional society explanation of visual phenomenology and aura with or without headache.